{# Drug is a Product subtype → Google requires offers. A generic spans many brands, so we expose the brand price range as an AggregateOffer. #}
🧬

Levocetirizine Dihydrochloride

Generic / Active Ingredient
Non-sedating antihistamines 30 brands 25 manufacturers Oral SolutionTablet

What is Levocetirizine Dihydrochloride used for?

Urticaria

30 Levocetirizine Dihydrochloride brands in Bangladesh

Compare prices across every brand of Levocetirizine Dihydrochloride and pick the most affordable option.

Brand Strength Form Manufacturer Price
Acitrin-L 2.5 mg/5 ml Oral Solution ACI Limited ৳ 55.00
Acitrin-L 5 mg Tablet ACI Limited ৳ 3.01
Alcet 2.5 mg/5 ml Oral Solution Healthcare Pharmaceuticals Ltd. ৳ 50.00
Alcet 5 mg Tablet Healthcare Pharmaceuticals Ltd. ৳ 4.50
Cevozin 5 mg Tablet Ad-din Pharmaceuticals Ltd. ৳ 2.00
Clarigen 5 mg Tablet Drug International Ltd. ৳ 2.00
Curin 5 mg Tablet Beximco Pharmaceuticals Ltd. ৳ 3.00
LVC 5 mg Tablet Organic Health Care Ltd. ৳ 3.01
Lecet 5 mg Tablet Pacific Pharmaceuticals Ltd. ৳ 3.00
Lecitin 5 mg Tablet Zenith Pharmaceuticals Ltd. ৳ 2.00
Lerex 5 mg Tablet Asiatic Laboratories Ltd. ৳ 2.00
Levant 5 mg Tablet Bristol Pharmaceuticals Ltd. ৳ 2.20
Levocet 5 mg Tablet Alco Pharma Ltd. ৳ 2.01
Levotiz 5 mg Tablet Euro Pharma Ltd. ৳ 2.50
Liset 5 mg Tablet MST Pharma ৳ 2.00
Lozin 5 mg Tablet Kemiko Pharmaceuticals Ltd. ৳ 3.01
Lupron 5 mg Tablet Kumudini Pharma Ltd. ৳ 2.50
Megatrol 5 mg Tablet Peoples Pharma Ltd. ৳ 2.00
Netis 2.5 mg/5 ml Oral Solution Opsonin Pharma Ltd. ৳ 50.00
Netis 5 mg Tablet Opsonin Pharma Ltd. ৳ 3.50
Polan 5 mg Tablet Globe Pharmaceuticals Ltd. ৳ 3.00
Purotrol 5 mg Tablet Square Pharmaceuticals Ltd. ৳ 3.51
Rinocet 5 mg Tablet Jenphar Bangladesh Ltd. ৳ 4.00
Rinotin 5 mg Tablet Biopharma Laboratories Ltd. ৳ 3.00
Seasonix 2.5 mg/5 ml Oral Solution Incepta Pharmaceuticals Ltd. ৳ 55.00
Seasonix 5 mg Tablet Incepta Pharmaceuticals Ltd. ৳ 4.00
Sinacet 2.5 mg/5 ml Oral Solution Ibn Sina Pharmaceuticals Ltd. ৳ 50.00
Sinacet 5 mg Tablet Ibn Sina Pharmaceuticals Ltd. ৳ 4.00
Verizin 5 mg Tablet Sharif Pharmaceuticals Ltd. ৳ 2.00
Vocet 5 mg Tablet Apex Pharmaceuticals Ltd. ৳ 2.00

Levocetirizine Dihydrochloride — Clinical Information

Indication DetailsView
Levocetirizine is indicated in the treatment of symptoms associated with allergic conditions such as perennial allergic rhinitis, seasonal allergic rhinitis and chronic idiopathic urticaria.
Therapeutic ClassView
Non-sedating antihistamines
PharmacologyView
This preparation contains Levocetirizine Dihydrochloride. Levocetirizine is the active (Levo) isomer of cetirizine. It is a new highly effective and well-tolerated nonsedating antihistamine with potent antiallergic properties. It has a two-fold higher affinity for H1 receptors than cetirizine. Levocetirizine has a rapid and long-acting action, allowing once-a-day administration.
DosageView
Adult and children 12 years of age and older: The recommended dose is 5 mg once daily.

Children 6 to 11 years of age: The recommended dose is 2.5 mg (1/2 tablet or 1 teaspoon oral solution) once daily.

Children 6 months to 5 years of age: The recommended dose is 1.25 mg (1/2 teaspoon oral solution) once daily.
Side EffectsView
Generally, levocetirizine is well tolerated. However, a few side effects like headache, dry mouth, fatigue and skin rash have been reported rarely.
ContraindicationsView
Hypersensitivity to levocetirizine, cetirizine or its parent compound hydroxyzine. Patients with severe renal impairment (creatinine clearance: <10 ml/min) should not be administered levocetirizine.
PrecautionsView
Epileptic patients and patients at risk of convulsions. Renal impairment. Pregnancy and lactation.
InteractionsView
Levocetirizine is not known to have any interactions with other drugs.
Pregnancy & LactationView
Pregnancy Catagory B. There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, levocetirizine should be used during pregnancy only if clearly needed. Since levocetirizine is excreted in breast milk it is not recommended for use by nursing mothers.
Pediatric UsageView
Pediatric use: The recommended dose for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in patients 6 months to 17 years of age is based on extrapolation of efficacy from adults 18 years of age and older.

Geriatric use: In clinical studies, each approved indication did not include sufficient numbers of patients aged 65 years and older to determine whether they respond differently than younger patients.

Hepatic impairment: No dosage adjustment is required in patients with solely hepatic impairment.

Renal impairment:
  • Mild renal impairment (creatinine clearance: 50-80 ml/min): a dose of 2.5 mg once daily is recommended.
  • Moderate renal impairment (creatinine clearance: 30-50 ml/min): a dose of 2.5 mg once every other day is recommended.
  • Severe renal impairment (creatinine clearance: 10-30 ml/min): a dose of 2.5 mg twice weekly (administered once every 3-4 days) is recommended.
  • End-stage renal disease patients (creatinine clearance: <10 ml/min) and patients undergoing hemodialysis: should not receive Levocetirizine.
Overdose EffectsView
No clinically relevant adverse events have been reported in case of overdose. However in the event of overdosage, symptomatic and supportive treatment is recommended.
Storage ConditionsView
Store at a temperature not exceeding 30°C in a dry place. Protect from light.